Trade Summary

3 days ago, Bennett C Frank, serving as EVP, Chief Scientific Officer at Ionis Pharmaceuticals Inc (IONS), sold 85,089 shares at $79.23 per share, for a total transaction value of $6,741,669.00. Following this transaction, Bennett C Frank now holds 80,554 shares of IONS.

This sale represents a 51.00% decrease in Bennett C Frank's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 2 days after the trade was made.

Ionis Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.